Mutation of Tyrosine 960 within the Insulin Receptor Juxtamembrane Domain Impairs Glucose Transport but Does Not Inhibit Ligand-mediated Phosphorylation of Insulin Receptor Substrate-2 in 3T3-L1 Adipocytes
Open Access
- 1 April 1999
- journal article
- Published by Elsevier
- Vol. 274 (17) , 12075-12080
- https://doi.org/10.1074/jbc.274.17.12075
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Anti-apoptotic Signaling by a Colony-stimulating Factor-1 Receptor/Insulin Receptor Chimera with a Juxtamembrane DeletionJournal of Biological Chemistry, 1998
- CSF-1 Receptor/Insulin Receptor Chimera Permits CSF-1-dependent Differentiation of 3T3-L1 PreadipocytesPublished by Elsevier ,1997
- Mutational analysis of insulin receptor functionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- A monoclonal anti-peptide antibody reacting with the insulin receptor β-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptorsBiochemical Journal, 1992
- Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activityCell, 1988
- Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mappingBiochemical Journal, 1988
- High-level expression of human insulin receptor cDNA in mouse NIH 3T3 cells.Proceedings of the National Academy of Sciences, 1987
- Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminusNature, 1986
- The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signallingCell, 1985
- Human insulin receptor and its relationship to the tyrosine kinase family of oncogenesNature, 1985